American Health Line rounds up the latest health care news in the states.

The House on Tuesday voted to approve two major spending packages that would allocate a total of nearly $1.4 trillion to fund the federal government, including health agencies, through the end of fiscal year 2020.

Congressional negotiators on Monday released a nearly $1.4 trillion spending agreement that would fund the federal government, including health agencies, through the end of fiscal year 2020 and includes several health care provisions—such as measures to permanently repeal three Affordable Care Act taxes, delay cuts to Medicaid disproportionate-share hospital payments, raise the minimum tobacco purchasing age, and more.

Glassdoor on Wednesday released its annual Employees' Choice Awards for the Best Places to Work in 2020, and 21 health care and health care-adjacent organizations were recognized.

The Senate on Thursday voted 72-18 to confirm President Trump's nomination of Stephen Hahn to serve as FDA commissioner.

The House on Thursday voted 230-291 to pass House Speaker Nancy Pelosi's (D-Calif.) bill intended to lower prescription drug prices in the United States, and voted 201-223 to reject a bill introduced by House Republicans that was intended to serve as an alternative to Pelosi's measure.

A provision in House Speaker Nancy Pelosi's (D-Calif.) drug pricing bill that would allow the HHS secretary to negotiate prescription drug prices would save the federal government about $456 billion from 2020-2029, but the bill would raise federal spending in other areas, according a Congressional Budget Office report released Tuesday.

The House Ways and Means Committee on Tuesday announced that Congress and the Trump administration have agreed on a renegotiated North American Free Trade Agreement between the United States, Canada, and Mexico that does not include a 10-year exclusivity period for biologic drugs that was backed by pharmaceutical companies.

Leaders on the Senate Finance Committee on Friday unveiled a new, bipartisan bill intended to lower prescription drug prices, and House Republicans on Monday announced a similar bill—both of which clash with a separate proposal introduced earlier this year by House Speaker Nancy Pelosi (D-Calif.).

Forbes this week released its annual "30 Under 30 in Healthcare" list, which includes biological researchers, entrepreneurs, physicians, and PhD students under 30 years of age who are "tackling health care issues at every scale."